Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Iron Ore
100.85
2.03%
Lithium
41.54
0.1%
Gold
2,615.90
(0.77%)
Copper
4.09
(0.87%)
Oil
71.54
1.59%
Bitcoin
92,243.05
(1.4%)
USD/AUD
0.62
0.02%
FTSE 100
8,121.01
(0.35%)
Nikkei 225
39,894.54
(1.07%)
Dow Jones
42,691.33
(0.4%)
Hang Seng
20,041.42
(0.41%)
Radiopharm Theranostics (ASX: $RAD) receives ethics approval for phase 1 trial
- Author: Stock Piper
Radiopharm Theranostics advances clinical trial efforts
Radiopharm Theranostics (ASX:RAD) has received ethics approval from the Belberry Human Research Ethics Committee in Australia to begin a Phase 1 First-In-Human clinical trial. The trial, named 'HEAT', will assess the safety and clinical activity of 177Lu-RAD202 in HER2-positive metastatic solid tumors.
Radiopharm Theranostics' strategic trial outlook
Radiopharm Theranostics has received ethics approval to commence a Phase 1 clinical trial in Australia, focusing on HER2-positive metastatic cancers like breast and gastric cancers. The 'HEAT' trial will evaluate the safety and preliminary clinical activity of 177Lu-RAD202, building on promising results from previous studies. The company aims to provide a new treatment option for patients who do not respond to existing therapies, enhancing clinical outcomes and quality of life. As a clinical-stage biopharmaceutical company, Radiopharm Theranostics continues to advance its radiopharmaceutical pipeline targeting various solid tumors.
Executive commentary on trial approval
Receiving ethics approval for our 'HEAT' trial is a significant milestone for Radiopharm Theranostics. This advancement allows us to explore a potential new treatment option for patients with HER2-positive metastatic cancers.
RADIOPHARM THERANOSTICS LIMITED
RAD | ASX | Health Care
0.0230(+0%)
At close 27/12 (AEDT)
Market cap
$50.6M
Volume
9,672,799
DY Yield
PE Ratio
52 Week Range
0.021 - 0.1
1YR Return
N / A
Login
Please login to comment
0 Comments
ASX News, First
& Fast.
By clicking Subscribe, you agree to our Terms & Conditions
ASX News, First And Fast.
By clicking Subscribe, you agree to our Terms & Conditions
© 2024 Stock Piper.
All rights reserved
All rights reserved
Support
© 2024 Stock Piper. All rights reserved
Social Media Auto Publish Powered By : XYZScripts.com
Stock Piper AI Index Coming Soon!
Join our Newsletter to gain exclusive insight and be notified once we are live.
By clicking Subscribe, you agree to our Terms & Conditions
ASX News, First And Fast.
Get all the latest market updates straight to your inbox.
By clicking Subscribe, you agree to our Terms & Conditions